Buy Tests

Swab

Swab both nostrils using medium pressure. Insert the swab approximately 1/2″-3/4″ (no deeper) and make at least 5 circles, swabbing the inner sides of each nostril. Take approximately 15 seconds per nostril.

Plunge

Immediately plunge the swab into the vial and slowly move it up and down for 10 seconds before leaving the swab to sit in the vial for 1 minute.

Pour

Place the test cassette on a flat level surface, remove the swab from the vial, squeezing out any excess liquid against the vial’s inner side, and pour all of the liquid content of the vial into the circular well on the test cassette.

Wait for results

Set a timer and read the result of the test after 20 minutes.

ASSURE-100 Rapid COVID-19 Home Tests

The ASSURE-100 Rapid COVID-19 Home Test provides accurate, reliable results in just 20 minutes, using a shallow nasal swab for enhanced comfort. This innovative rapid test makes COVID-19 testing fast, easy, and accessible, empowering individuals to monitor their health effectively from home.

Developed in Hawai’i by Oceanit, a cutting-edge technology company with a team of just 200 people, the ASSURE-100 was granted two FDA authorizations in 2022. These approvals allow the test to be used globally by healthcare professionals and at home without requiring a prescription, expanding access to critical diagnostic tools.

Founded in 1985 in Honolulu, Hawai’i, Oceanit has built a world-class reputation for groundbreaking science and disruptive innovation. Guided by core values of curiosity, community, and ohana (family), Oceanit’s team of scientists, engineers, and innovators addresses some of the world’s most complex challenges, including advancing solutions for the ongoing COVID-19 pandemic.

Oceanit Foundry LLC is a subsidiary company of Oceanit Labs, Inc.

From Hawaii to the World.

The ASSURE-100 Rapid COVID-19 Home Test was FDA Emergency Use Authorized in December, 2022. The test was developed by scientists and engineers at Oceanit Laboratories, delivering a world-class diagnostic tool from Hawaii to the rest of the world.

The ASSURE-100 Rapid COVID-19 Test Kit, developed by Oceanit in Honolulu, Hawai‘i, USA, empowers communities to fight COVID-19 with fast, reliable testing. Designed for convenience and accuracy, the ASSURE-100 was granted two Emergency Use Authorizations (EUAs) by the U.S. Food and Drug Administration (FDA) in 2022:

For point-of-care use by healthcare professionals.
For over-the-counter (OTC) at-home use.
Oceanit, a Hawai‘i-based technology company, is dedicated to protecting communities from current and future COVID-19 outbreaks. By combining innovation with a deep commitment to public health, Oceanit continues to develop tools that prioritize safety and accessibility.

The ASSURE-100 Rapid Test Kit is available for purchase online, with options for local Hawai‘i delivery or pickup. For bulk orders, please contact us using the button below.

Bulk Orders
For use under FDA Emergency Use Authorization (EUA) only.

Self-test at home with ASSURE

As new COVID-19 variants emerge, everyone—regardless of age or vaccination status—remains vulnerable to infection. Early and frequent testing is essential to safeguard your friends, family, and community from potential exposure. The ASSURE-100 Rapid COVID-19 Home Test offers a simple, fast, and convenient way to monitor your health from the comfort of home.

This FDA-authorized test delivers accurate, reliable results in just 20 minutes, using a shallow nasal swab for improved comfort. With the ASSURE-100, taking control of your health has never been easier or more accessible.

Learn More About At-Home Tests
For use under FDA Emergency Use Authorization (EUA) only.

Protect your Organization with ASSURE

The ASSURE Integrated Care Platform offers a fast, accurate, and scalable COVID-19 testing solution for organizations of all types and sizes, including businesses, public sector entities, schools, and more. Whether testing on-site or in employee homes, the ASSURE-100 Rapid COVID-19 Test streamlines frequent, reliable testing with its simplicity and user-friendly design. Its shallow nasal swab also ensures a more comfortable testing experience.

The ASSURE-100 Rapid COVID-19 Test is straightforward and intuitive, consisting of just three components: a nasal swab, a solution vial, and a test cassette. This design enables organizations to implement testing programs with ease, protecting employees, clients, and communities.

Contact Us To Learn More
For use under FDA Emergency Use Authorization (EUA) only.

Spread Aloha, Not Covid with the ASSURE-100 Rapid Covid-19 Test

Keep your loved ones and community safe with Simple, Fast and Accurate testing.

Frequently Asked Questions

Frequently asked questions to help you learn more about ASSURE rapid tests.
1. What is ASSURE-100?
K
L

ASSURE-100 is a rapid COVID-19 test that uses an anterior nasal specimen to detect COVID-19, the disease caused by the SARS-CoV-2 virus. ASSURE is an acronym for: Accelerated Sensor Solution for Urgent Response to Epidemics.

2. Where was ASSURE-100 developed?
K
L

The ASSURE technology and ASSURE-100 rapid COVID-19 test was developed by Oceanit in Hawaiʻi and was put through testing and clinical trials in Hawaii and in other states across the US.

3. How do ASSURE tests work?
K
L
ASSURE-100 uses shallow nasal specimens to detect COVID-19 using a lateral flow assay (LFA) test cassette. A shallow anterior nasal swab specimen is mixed with buffer solution and then poured into the well on the test cassette. ASSURE tests are visually read, and do not require an external device to interpret results.
4. Does ASSURE-100 Rapid COVID-19 Home Test detect Omicron variants?
K
L
Yes, the ASSURE-100 Rapid COVID-19 Home Test clinical trial included BA.2.12.1 and BA.2 variant samples. Additionally, the ASSURE-100 test was evaluated in a dilution series of clinical specimens positive for the Omicron variants BA.5 and BE.1. This testing was conducted by National Institutes of Health (NIH) as a component of the Rapid Acceleration of Diagnostics (RADx) initiative. Results indicate that ASSURE-100 detects both BA.5 and BE.1 variants.
5. How quickly will ASSURE-100 detect a result if positive?
K
L
Results should be read at 20 minutes.

Get in touch via email

If you have any questions please contact us at info@assure-test.com or by clicking the button below. Alternatively, you can get in touch by filling the contact form.

E-mail us

Contact us using the form below

    The ASSURE-100 Rapid COVID-19 POC Test is available by FDA Emergency Use Authorization (EUA) only. For more information click here.

    The ASSURE-100 Rapid COVID-19 POC Test that has been authorized by the U.S. FDA under an emergency use authorization for use by CLIA and CLIA waived laboratories in Point of Care settings. The ASSURE-100 Rapid COVID-19 Test is for use by authorized laboratories for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner. The ASSURE-100 Rapid COVID-19 Test has not been FDA approved.

    The ASSURE-100 Rapid COVID-19 Home Test is available by FDA Emergency Use Authorization (EUA) only. For more information click here.

    The ASSURE-100 Rapid COVID-19 Home Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA; this product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.